Prot #CD-RI-CAT-354-1066: A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults with Idiopathic Pulmonary Fibrosis

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date3/28/143/28/17

    Funding

    • PPD Development (Prot #CD-RI-CAT-354-1066)
    • MedImmune, LLC (Prot #CD-RI-CAT-354-1066)